Literature DB >> 27366671

Is hypomagnesemia associated with using proton pump inhibitors?

Joo-Hark Yi1, Sang-Woong Han1.   

Abstract

Entities:  

Year:  2016        PMID: 27366671      PMCID: PMC4919590          DOI: 10.1016/j.krcp.2016.04.002

Source DB:  PubMed          Journal:  Kidney Res Clin Pract        ISSN: 2211-9132


× No keyword cloud information.
To the Editor: Proton pump inhibitors (PPIs) have been very useful in various gastrointestinal diseases. However, hypomagnesemia was reported in patients taking PPIs, and cross-sectional or retrospective studies for a causal relationship between PPIs and hypomagnesemia were carried out. Until now, this question remains unresolved although a recent meta-analysis study concluded that PPI use may increase the risk of hypomagnesemia [1]. In the past issue of this Journal, Park et al [2] added a controversy to the association between hypomagnesemia and the PPI use. This study was interesting because it was performed on a relatively homogeneous population, who was undergoing percutaneous coronary intervention and whose basal serum magnesium level was normal. The authors made an effort to demonstrate the relationship through various subgroup analyses. However, in this study protocol, the definition of PPI group is not sufficient for detailed history about taking PPIs, as it was uncertain when PPI usage began. The authors may need to show more data regarding previous PPI usage, serum magnesium level before starting PPIs, and the proportion of patients with previous PPI usage before enrollment. Despite previous PPI usage, some patients in the PPI group may consistently maintain magnesium levels in normal range during the study period. Furthermore, in the previous reports [3], [4], the association between PPI use and a low serum magnesium level was observed among population with higher prevalence of hypomagnesemia, ranging from 6% to 24%. The authors already pointed out a very low incidence of hypomagnesemia in the study population. Unlike calcium balance, magnesium is not readily mobilized from the bone stores. However, if negative magnesium balance continues, the bone stores help to maintain serum magnesium concentration [5]. Therefore, PPI exposure may induce only modest or no significant changes in serum magnesium concentration among patients with normal range of serum magnesium.
  8 in total

Review 1.  Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Wonngarm Kittanamongkolchai; Narat Srivali; Peter J Edmonds; Patompong Ungprasert; Oisin A O'Corragain; Sira Korpaisarn; Stephen B Erickson
Journal:  Ren Fail       Date:  2015-06-25       Impact factor: 2.606

2.  Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.

Authors:  Brenda C T Kieboom; Jessica C Kiefte-de Jong; Mark Eijgelsheim; Oscar H Franco; Ernst J Kuipers; Albert Hofman; Robert Zietse; Bruno H Stricker; Ewout J Hoorn
Journal:  Am J Kidney Dis       Date:  2015-06-26       Impact factor: 8.860

Review 3.  Effects of magnesium on skeletal metabolism.

Authors:  S Wallach
Journal:  Magnes Trace Elem       Date:  1990

4.  The association of proton pump inhibitors and hypomagnesemia in the community setting.

Authors:  Noa Markovits; Ronen Loebstein; Hillel Halkin; Martin Bialik; Janet Landes-Westerman; Joseph Lomnicky; Daniel Kurnik
Journal:  J Clin Pharmacol       Date:  2014-05-06       Impact factor: 3.126

5.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

6.  Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.

Authors:  Ala I Sharara; Jean M Chalhoub; Nijmeh Hammoud; Ali H Harb; Fayez S Sarkis; Ghassan Hamadeh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 11.382

7.  Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention.

Authors:  Sang-Ho Park; Sun-Hyo Lee; Ji-Sung Lee; Won-Yong Shin; Hyo-Wook Gil; Jong-Oh Yang; Eun-Young Lee; Sae-Yong Hong
Journal:  Kidney Res Clin Pract       Date:  2015-03-27

Review 8.  The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.

Authors:  Chan Hyuk Park; Eun Hye Kim; Yun Ho Roh; Ha Yan Kim; Sang Kil Lee
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.